THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES) for THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES)
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report | Jul 21, 2025 | $1,890,000 | Replaced |
| 2nd Quarter - Amendment (this page) | Oct 20, 2025 | $1,930,000 | Yes |
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Labor Issues/Antitrust/Workplace LBR
Issues related to competition in the health care marketplace.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRENDAN DEVINE | — |
| CHRISTOPHER HARTMANN | — |
| KARA SMITH New | Deputy Chief of Staff and Legislative Director, Sen. Kit Bond |
Medicare/Medicaid MMM
P.L. 117-169, the Inflation Reduction Act of 2022; H.R. 4189/S. 2016, The Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2023; Issues related to transparency and prior authorization.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER HARTMANN | — |
| COURTNEY LAWRENCE | — |
| KARA SMITH New | Deputy Chief of Staff and Legislative Director, Sen. Kit Bond |
Health Issues HCR
S. 864/H.R. 247, the Health Care Affordability Act of 2025 and issues relating to extension of Enhanced Advanced Premium Tax Credits (EAPTCs) including in the American Rescue Plan Act (ARPA) and the Inflation Reduction Act (IRA); Issues related to P.L.119-21 (H.R. 1), the One Big Beautiful Bill Act, and budget reconciliation; Issues related to H.R. 2041, the Hidden Fee Disclosure Act of 2025.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRENDAN DEVINE | — |
| KATHRYN GALLAGHER | — |
| CHRISTOPHER HARTMANN | — |
| COURTNEY LAWRENCE | — |
| JULIEN MITCHELL RELFE | — |
| KARA SMITH New | Deputy Chief of Staff and Legislative Director, Sen. Kit Bond |
Defense DEF
Pharmacy issues related to the National Defense Authorization Act, FY2026.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRENDAN DEVINE | — |
| CHRISTOPHER HARTMANN | — |
| JULIEN MITCHELL RELFE | — |
| KARA SMITH New | Deputy Chief of Staff and Legislative Director, Sen. Kit Bond |
Pharmacy PHA
S. 1542/H.R.2214, the DRUG Act; H.R. 5378 Lower Costs, More Transparency Act; S. 1339, Pharmacy Benefit Manager Reform Act; S.526, Pharmacy Benefit Manager Transparency Act; S. 1040, The Drug Competition and Enhancement Act; S. 1041, The Affordable Prescriptions for Patients Act; Issues related to the specialty drug market.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRENDAN DEVINE | — |
| KATHRYN GALLAGHER | — |
| CHRISTOPHER HARTMANN | — |
| COURTNEY LAWRENCE | — |
| JULIEN MITCHELL RELFE | — |
| KARA SMITH New | Deputy Chief of Staff and Legislative Director, Sen. Kit Bond |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.